$14.65
0.060.43%
At close: -
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
2.43M
Fund Score
WisdomTree BioRevolution Fund (BATS:WDNA) Quotes, Forecast and News Summary
WisdomTree BioRevolution Fund (BATS: WDNA) stock price, news, charts, stock research, profile.
| Open | $14.63 |
| High | $14.65 |
| 52 Wk High | $17.96 |
| AUM | 2.43M |
| Dividend | $0.14 |
| Ex-Div Date | Dec 22, 2023 |
| Volume | 213 |
| Market Cap | $40.41B |
| Mgmt Fee | 0.45% |
| P/E Ratio | 24.80 |
| Prev. Close | $14.59 |
| Low | $14.63 |
| 52 Wk Low | $14.31 |
| Shares Out | 150.00K |
| Yield | 0.84% |
| Div. Freq | Annual |
| Avg. Volume Daily | 754.00 |
| Beta | 1.05 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 2.52 |
Recent News
No news found
FAQ
Q
How do I buy WisdomTree BioRevolution Fund (WDNA) stock?
A
You can purchase shares of WisdomTree BioRevolution Fund (BATS:WDNA) through any online brokerage.
Q
Who are WisdomTree BioRevolution Fund (WDNA) competitors?
A
There are no as such competitors for WisdomTree BioRevolution Fund.
Q
What is the forecast, or price target, for WisdomTree BioRevolution Fund (WDNA) stock?
A
There is no analysis for WisdomTree BioRevolution Fund to provide a consensus price target.
Q
What is the current price for WisdomTree BioRevolution Fund (WDNA)?
A
The stock price for WisdomTree BioRevolution Fund (BATS: WDNA) is $14.82 last updated November 18, 2024 at 9:28 AM EST.
Q
Does WisdomTree BioRevolution Fund (WDNA) pay a dividend?
A
There are no upcoming dividends for WisdomTree BioRevolution Fund.
Q
When is WisdomTree BioRevolution Fund (BATS:WDNA) reporting earnings?
A
WisdomTree BioRevolution Fund does not have any upcoming earnings scheduled.
Q
Is WisdomTree BioRevolution Fund (WDNA) going to split?
A
There is no upcoming split for WisdomTree BioRevolution Fund.
| Open | $14.63 |
| High | $14.65 |
| 52 Wk High | $17.96 |
| AUM | 2.43M |
| Dividend | $0.14 |
| Ex-Div Date | Dec 22, 2023 |
| Volume | 213 |
| Market Cap | $40.41B |
| Mgmt Fee | 0.45% |
| P/E Ratio | 24.80 |
| Prev. Close | $14.59 |
| Low | $14.63 |
| 52 Wk Low | $14.31 |
| Shares Out | 150.00K |
| Yield | 0.84% |
| Div. Freq | Annual |
| Avg. Volume Daily | 754.00 |
| Beta | 1.05 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 2.52 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Jun 1, 2021 |
| Managers | Michael Stoll Vlasta Sheremeta Todd Frysinger Marlene Walker-Smith David France |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Fund employs a passive management – or indexing – investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved